Bill C-265 — Law Would Speed Up Access to Unapproved Medicines
Faster Access to Medicines
This proposed law aims to change how Canadians can access drugs that aren't yet approved for sale in Canada. It would create a list of drugs that are pre-approved for special access. Doctors could then request these drugs for their patients more easily, especially for serious or life-threatening conditions when no other suitable treatment is available. This change would mostly affect patients with serious illnesses, rare diseases, or those who have exhausted other treatment options. It would also affect doctors, pharmacists, hospitals, and drug companies. The government would create a committee of experts to help decide which drugs should be on the list. The government would also track how these drugs are used and make sure they are safe. This matters because it could give patients access to potentially life-saving treatments sooner. It could also give doctors more options when treating complex or rare conditions. The proposed law also aims to ensure that the process is safe and transparent, with the government monitoring the use of these drugs and making information available to the public.
Where this proposed law falls on the policy spectrums that Canadians care about
Set your 3 priorities to see how this bill aligns with what you care about.
Sign up free — 30 secThis proposed law creates a list of pre-approved, non-marketed drugs for serious conditions when no other option exists in Canada. It aims to give patients faster access to needed treatments, but relies heavily on the Minister's discretion and leaves some practical details unclear.
Things to Watch For
- The law doesn't specify how the Minister will ensure fair drug pricing.
- It is unclear how the Minister will handle situations where the advisory committee's advice conflicts with their own views.
- The law does not address how patients can appeal if a needed drug is not added to the list.
- The definition of 'non-marketed' could be clearer to avoid loopholes.
- The lack of remuneration for the advisory committee members may limit participation.
Click any step to learn what it means
Loading...
Click any step to learn what it means
Loading...
How likely this proposed law is to be approved
This is a private member's proposed law that is low in priority. These rarely pass unless they have broad support from all parties.
Sign in to join the discussion.
Loading comments...